breast cancer develop resistance to hormone treatment, and a potential new approach to overcome the problem. Around 80% of breast cancers are ER+ and are treated with anti-oestrogen therapies such as ...
This is the second installment of a three-part series on breast cancer.] The most common breast cancer symptom is a lump. Other symptoms include swelling, skin irritation, nipple pain or ...
well-controlled clinical studies have established the efficacy and safety of initial adjuvant therapy with letrozole or anastrozole versus the previous standard of 5 years of adjuvant tamoxifen ...
来自MSN1 个月
Clinical trial: Adjuvant tamoxifen may reduce recurrence risk for patients with 'good-risk ..."Tamoxifen, radiation, or both, as well as the omission of any adjuvant therapy, are all reasonable options," she said. "Now, we have more data to help our patients choose among these ...
Background: Tamoxifen (Tam) is used for the treatment and prevention of estrogen-receptor-positive human breast and other cancers. Its use in ovarian cancer has not been well studied. Method ...
The therapies that protect you from recurrence—life-saving treatments like tamoxifen and aromatase ... For many, the side effects of hormone therapy—crippling anxiety, sexual dysfunction ...
advise that patients who undergo breast-conserving surgery after a diagnosis of hormone receptor-positive DCIS consider tamoxifen after surgery, whether or not they concurrently receive radiotherapy.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果